NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,099,670 | -20.3% | 109,244 | +5.4% | 0.00% | -33.3% |
Q2 2023 | $2,634,961 | -4.7% | 103,657 | +35.5% | 0.01% | 0.0% |
Q1 2023 | $2,766,306 | +177.0% | 76,523 | +203.5% | 0.01% | +200.0% |
Q4 2022 | $998,554 | -19.2% | 25,216 | -4.9% | 0.00% | -33.3% |
Q3 2022 | $1,236,000 | +191.5% | 26,523 | +173.9% | 0.00% | +200.0% |
Q2 2022 | $424,000 | -74.9% | 9,684 | -58.6% | 0.00% | -66.7% |
Q1 2022 | $1,691,000 | +175.0% | 23,375 | +207.9% | 0.00% | +200.0% |
Q4 2021 | $615,000 | -64.1% | 7,591 | -48.5% | 0.00% | -66.7% |
Q3 2021 | $1,715,000 | +35.1% | 14,739 | +92.6% | 0.00% | +50.0% |
Q2 2021 | $1,269,000 | -2.4% | 7,653 | -17.9% | 0.00% | 0.0% |
Q1 2021 | $1,300,000 | -54.7% | 9,319 | -43.8% | 0.00% | -60.0% |
Q4 2020 | $2,869,000 | -14.0% | 16,574 | -30.8% | 0.01% | -16.7% |
Q3 2020 | $3,335,000 | +10.5% | 23,939 | -5.3% | 0.01% | +20.0% |
Q2 2020 | $3,019,000 | +116.9% | 25,274 | +81.5% | 0.01% | +150.0% |
Q1 2020 | $1,392,000 | +26.9% | 13,922 | +49.2% | 0.00% | +100.0% |
Q4 2019 | $1,097,000 | +293.2% | 9,332 | +167.4% | 0.00% | – |
Q2 2018 | $279,000 | -11.7% | 3,490 | -4.2% | 0.00% | – |
Q1 2018 | $316,000 | +21.1% | 3,642 | -3.6% | 0.00% | – |
Q4 2017 | $261,000 | -37.7% | 3,779 | -18.0% | 0.00% | -100.0% |
Q3 2017 | $419,000 | -60.1% | 4,607 | -67.4% | 0.00% | 0.0% |
Q2 2017 | $1,051,000 | -1.5% | 14,117 | +24.0% | 0.00% | 0.0% |
Q1 2017 | $1,067,000 | -11.7% | 11,386 | -31.6% | 0.00% | -50.0% |
Q4 2016 | $1,209,000 | -29.1% | 16,635 | +1.8% | 0.00% | -33.3% |
Q3 2016 | $1,706,000 | +74.1% | 16,340 | +23.0% | 0.00% | +50.0% |
Q2 2016 | $980,000 | +31.0% | 13,289 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $748,000 | +16.7% | 13,289 | +40.0% | 0.00% | 0.0% |
Q4 2015 | $641,000 | – | 9,491 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |